Trial Profile

A Randomized, Double-Blind, Multicenter, Phase 3 Study to Evaluate Efficacy and Safety of HCP1306 Tablet in Patients With Primary Hypercholesterolemia

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 20 Nov 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ezetimibe/rosuvastatin (Primary) ; HGP 0816
Indications Hypercholesterolaemia
Focus Registrational; Therapeutic Use
Acronyms MRS-ROZE
Sponsors Hanmi Pharmaceutical

Most Recent Events

11 Nov 2019 Results (n=407) of post-hoc analysis assessing combination treatment with ezetimibe and rosuvastatin in patients with hupercholesterolemia, published in the Clinical Therapeutics.
21 Sep 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
05 Aug 2014 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com